1763 — China Isotope & Radiation Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Annual cashflow statement for China Isotope & Radiation, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	734	596	803	921	922
Depreciation
Non-Cash Items	-61.3	-30.3	-43.6	-31.6	-140
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-202	-446	-162	-249	-962
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	602	292	794	863	85
Capital Expenditures	-591	-410	-428	-576	-898
Purchase of Fixed Assets
Other Investing Cash Flow Items	-518	-14	-480	45.5	468
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,108	-424	-907	-531	-430
Financing Cash Flow Items	581	40.2	-103	-102	-169
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	591	-156	-97.4	-238	484
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	82.8	-289	-210	93.7	140